Severe cicatricial alopecia as a rare cutaneous side effect due to erlotinib – case report

Severe cicatricial alopecia as a rare cutaneous side effect due to erlotinib – case report

Introduction . Epidermal growth factor receptor inhibitors (EGFRI) are commonly used in the treatment of solid tumors. Cutaneous side effects occur in 80% of patients and are the most frequent adverse events. However, cicatricial alopecia is a rarely described side effect of EGFRI. Objective . To...

Full description

Bibliographic Details
Main Authors: Magdalena Żychowska, Aleksandra Batycka-Baran, Wojciech Baran, Joanna Maj
Format: Article
Language:English
Published: Termedia Publishing House 2016-10-01
Series:Przegląd Dermatologiczny
Subjects:
erlotinib
alopecia
cicatricial alopecia
epidermal growth factor receptor inhibitors
Online Access:https://www.termedia.pl/Severe-cicatricial-alopecia-as-a-rare-cutaneous-side-effect-due-to-erlotinib-case-report,56,28518,1,1.html

Internet

https://www.termedia.pl/Severe-cicatricial-alopecia-as-a-rare-cutaneous-side-effect-due-to-erlotinib-case-report,56,28518,1,1.html

Similar Items